MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
OPTN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

OptiNose (OPTN) Ownership - Who owns OptiNose?

Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin)... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Or Nursing Services
Address
1020 Stony Hill Road
Phone
+1 267 364-3500
Employees
132
Web
https://www.optinose.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
164.47M
P/E Ratio
N/A
Total Cash
73.68M
Projected Growth
N/A
Total Debt
131.75M
Revenue
70.99M
Risk (Beta)
-1.33
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
0.63 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for OPTN
A.I. Advisor
published General Information

General Information

a holding company which specializes in nasal and sinus diseases

Industry PharmaceuticalsOther

Profile
Details
Industry
Medical Or Nursing Services
Address
1020 Stony Hill Road
Phone
+1 267 364-3500
Employees
132
Web
https://www.optinose.com